The vein-banding disease syndrome: A synergistic reaction between grapevine viroids and fanleaf virus
DOI:
https://doi.org/10.5073/vitis.1995.34.229-232Keywords:
viroids, virus, fanleaf, yellow speckleAbstract
Viroid-free Vitis vinifera cultivars Cabernet Sauvignon and Sauvignon blanc were established in controlled field trials in California to evaluate the relationship between grapevine viroids and fanleaf virus for induction of the vein-banding disease. Vein-banding symptoms were observed only on vines which contained the three principal grapevine viroids, grapevine yellow speckle viroids (GYSVd-1, GYSVd-2), and hop stunt viroid (HSVd-g), as well as grapevine fanleaf virus (GFLV). Sauvignon blanc vines which contained the single viroid, HSVd-g, and GFLV were non-symptomatic indicating an absence of a correlation between HSVd-g and the vein-banding disease. The intensity of vein-banding symptoms was directly correlated with an enhanced titer of GYSVd-1 and GYSVd-2. Vein-banding and yellow speckle symptomatic as well as non-symptomatic vines in Italy contained two viroids, GYSVd-1 and HSVd-g. However, symptomatic vines displayed a higher titer of GYSVd-1 than non-symptomatic materials and vein-banding symptomatic vines were GFLV infected. These data experimentally demonstrate that expression of the vein-banding disease is induced by an unique synergistic reaction between a viroid, GYSVd-1 and a virus, GFLV.Downloads
Published
Issue
Section
License
The content of VITIS is published under a Creative Commons Attribution 4.0 license. Any user is free to share and adapt (remix, transform, build upon) the content as long as the original publication is attributed (authors, title, year, journal, issue, pages) and any changes to the original are clearly labeled. We do not prohibit or charge a fee for reuse of published content. The use of general descriptive names, trade names, trademarks, and so forth in any publication herein, even if not specifically indicated, does not imply that these names are not protected by the relevant laws and regulations. The submitting author agrees to these terms on behalf of all co-authors when submitting a manuscript. Please be aware that this license cannot be revoked. All authors retain the copyright on their work and are able to enter into separate, additional contractual arrangements.